Good Lifestyle

While coronavirus continues to spread in most parts of the world, there is a brilliant spot on the horizon for patients suffering from the most serious effects of the virus. A new study from the University of Oxford reveals that dexamethasone, aCorticosteroid drug frequently used for the treatment of conditions, including arthritis, psoriasis, allergies and asthma, can considerablyReduce the risk of coronavirus death in patients on the fans or receive oxygen.

Among a group of 2,104 topics of study, the administration ofDexamethasone has reduced the mortality rate for a third party's ventilated patients; In patients receiving oxygen, the mortality rate has been reduced by one fifth. But if these figures may seem promising, the treatment is not for everyone - the study revealed no reduction in the mortality rate in patients who received no oxygen treatments or fan support.

"Allergies and asthma are disorders resulting from an excess reaction by the immune system to harmless triggers such as pollen. Patients with COVIDs that suffer from a more serious illness have a similar excessive reaction of the immune system called a cytokine storm, "Leann Poston, MD, withMedical vibifier, RecountBetter life. "The mitigation of some of the inflammatory damage to the excessive reaction of the immune system can help protect the lungs, heart and blood vessels of damage."

"The survival benefit is clear and large in sufficiently sick patients to require oxygen treatment, so that dexamethasone must now become care for these patients", "chief investigatorPeter HorbyProfessor of emerging infectious diseases at the University of the University of Oxford's Department of Medicine, said in a statement.

RELATED:For more information up to date, sign up for our daily newsletter.

However, the long-term implications of drug use are still concerns. "The use of steroids is a risk-compared to benefits, because you bluze the immune response in a patient with an infection," says Poston.

While other treatments have been suggested as a way to improve the survival rates of COVID-19 patients, includingAntiviral drug codesivir andhydroxychloroquine, a drug frequently used to handle malaria, the Horby noted thatDexamethasone is the first treatment conclusively related to lower mortality rates in people with coronaviruses.

And although supply chain problems and the potential cost of bothcoronavirus vaccine And the treatment was cited as potential obstacles to the limitation of the pandemic, dexamethasone of horby dexamethasone and high availability. "Dexamethasone is inexpensive, on the shelf and can be used immediately to save lives around the world," he said. And for more insight in the fight against Covid-19, check these7 questions about the coronavirus vaccine, replied by doctors.